Archive for 2024

Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, is pleased to announce that it has successfully concluded an exclusive licensing agreement with the Republic of Korea-based Wooshin Labottach Co. LTD, for Lidocaine 700mg medicated plasters, in selected European Union (EU) markets.

Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, has concluded an exclusive licensing agreement (“Agreement”) with Swiss-based Devintec Pharma (“Devintec”) for Europe.

In January, the Aspen EME team gathered to start the new year 2024 and the post-merger journey with purpose, passion and unity. During this event held in Istanbul, we had the opportunity to get to know each other better, share experiences from our different markets, learn, and celebrate accomplishments. We also had the pleasure of…